Abstract |
Recently the Food and Drug Administration approved the drug foscarnet for treatment of cytomegalovirus retinitis. As with many other medications, foscarnet has some serious side effects and needs to be administered according to a standardized protocol. This article presents a protocol that was developed for the safe and appropriate delivery of foscarnet.
|
Authors | D G Smith Jr, C M Handy |
Journal | Journal of intravenous nursing : the official publication of the Intravenous Nurses Society
(J Intraven Nurs)
1992 Sep-Dec
Vol. 15
Issue 5
Pg. 274-7
ISSN: 0896-5846 [Print] United States |
PMID | 1336798
(Publication Type: Journal Article)
|
Chemical References |
|
Topics |
- Clinical Protocols
(standards)
- Cytomegalovirus Infections
(drug therapy, nursing)
- Foscarnet
(administration & dosage, adverse effects)
- Humans
- Patient Care Planning
- Retinitis
(drug therapy, nursing)
|